Target Name: MIR11400
NCBI ID: G113839523
Review Report on MIR11400 Target / Biomarker Content of Review Report on MIR11400 Target / Biomarker
MIR11400
Other Name(s): hsa-miR-11400 | hsa-mir-11400 | microRNA 11400 | MicroRNA 11400

MIR11400: A Potential Drug Target and Biomarker

Molecular Intelligence and Research

MIR11400 is a microRNA (miRNA) that has been identified as a potential drug target and biomarker for various diseases, including cancer. It is a non-coding RNA molecule that plays a crucial role in regulating gene expression and has been shown to be involved in a wide range of cellular processes, including cell growth, apoptosis, and inflammation.

The discovery of MIR11400 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. MIR11400 is a strong candidate for anti-cancer drugs because it has been shown to be involved in the regulation of cancer cell growth and survival.

One of the key features of MIR11400 is its ability to interact with various cellular signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in cell survival and growth, and has been implicated in the development of many diseases, including cancer. MIR11400 has been shown to be a positive regulator of the PI3K/Akt pathway and has been shown to promote the growth and survival of cancer cells.

Another potential drug target for MIR11400 is the NF-kappa-B signaling pathway. This pathway is involved in inflammation and cellular signaling and has been implicated in the development of many diseases, including autoimmune diseases and cancer. MIR11400 has been shown to be a negative regulator of the NF-kappa-B pathway and has been shown to protect against inflammation and cellular stress.

In addition to its potential drug target properties, MIR11400 has also been shown to be a potential biomarker for cancer. The expression of MIR11400 has been shown to be elevated in a variety of cancer types, including breast, ovarian, and prostate cancers. This suggests that MIR11400 may be a useful biomarker for the diagnosis and treatment of cancer.

The identification of MIR11400 as a potential drug target and biomarker has also implications for the development of new diagnostic tests for cancer. The expression of MIR11400 has been shown to be elevated in a variety of cancer types, including breast, ovarian, and prostate cancers. This suggests that MIR11400 may be a useful biomarker for the diagnosis of cancer.

In conclusion, MIR11400 is a microRNA that has been shown to have potential as a drug target and biomarker for various diseases, including cancer. Its ability to interact with various cellular signaling pathways and its potential as a negative regulator of the NF-kappa-B pathway make it a promising candidate for anti-cancer drugs. Further research is needed to fully understand the potential of MIR11400 as a drug target and biomarker for cancer.

Protein Name: MicroRNA 11400

The "MIR11400 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR11400 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282